[Pseudowasting syndrome and carcinogenesis after 20-methylcholanthrene administration and effects of Mycobacterium Calmette-Guérin (BCG) in newborn and young mice].
D000818:Animals; D000831:Animals, Newborn; D001284:Atrophy; D002471:Cell Transformation, Neoplastic / Q000276:immunology*; D003967:Diarrhea / Q000139:chemically induced; D006086:Graft vs Host Disease / Q000276:immunology*; D006130:Growth Disorders / Q000139:chemically induced; D006391:Hemangioma / Q000139:chemically induced; D007165:Immunosuppression Therapy; D007970:Leukopenia / Q000139:chemically induced; D008198:Lymph Nodes / Q000187:drug effects; D008748:Methylcholanthrene / Q000494:pharmacology*; D051379:Mice; D009163:Mycobacterium bovis / Q000276:immunology* / Q000472:pathogenicity; D009374:Neoplasms, Experimental / Q000276:immunology; D012513:Sarcoma, Experimental / Q000139:chemically induced; D013154:Spleen / Q000187:drug effects; D013950:Thymus Gland / Q000187:drug effects
D008748:Methylcholanthrene
Pseudowasting-Syndrom und Tumorbidung nach 20-Methylcholanthren sowie ihre Beeinflussung durch Mycobacterium Calmette-Guérin (BCG) bei neugeboren und jegundlichen Mäusen.